PURPOSE. To investigate the association between the microstructure of b-zone parapapillary atrophy (bPPA) and parapapillary deep-layer microvasculature dropout assessed by optical coherence tomography angiography (OCT-A).
b
-Zone parapapillary atrophy (bPPA), a feature of the glaucomatous eye, 1 is characterized by atrophy of the retinal pigment epithelium (RPE) and choriocapillaris adjacent to the optic disc. [1] [2] [3] It has been suggested that reduced blood supply to the optic nerve head (ONH) due to closure of the choriocapillaris may be a mechanism that accounts for the relationship between the bPPA and glaucoma. [1] [2] [3] [4] [5] Specifically, characteristics of the deep-layer microvasculature contained within the bPPA may differ according to whether Bruch's membrane (BM) is present (bPPA þBM ), or discontinuous or absent (c-zone PPA [cPPA] ). 3, [6] [7] [8] [9] [10] [11] [12] In cPPA areas devoid of the BM, parapapillary deep-layer microvasculature is composed of the microvasculature located within the elongated scleral flange. 3, 12 In contrast, in bPPA þBM areas, deep-layer microvasculature is only composed of the choriocapillaris. 6, 12 However, little is known about this issue since noninvasive visualization of the deep-layer microvasculature has not been possible until the recent development of optical coherence tomography angiography (OCT-A). OCT-A enables visualization of both deeplayer and superficial microvasculature. 6, [12] [13] [14] [15] [16] [17] The objective of the present study is to elucidate the association between the microstructure of the bPPA and the deep-layer microvasculature dropout in primary open-angle glaucoma (POAG) patients. Accountability Act. Informed consent was obtained from all participants. 12 
Study Subjects
Established POAG patients who had good-quality OCT-A images (Angiovue; Optovue, Inc., Fremont, CA, USA) and radial ONH images using both spectral-domain OCT (SD-OCT) (Spectralis; Heidelberg Engineering GmbH, Heidelberg, Germany) and swept-source OCT (SS-OCT) images (DRI-OCT; Topcon, Tokyo, Japan) were enrolled. All subjects completed an ophthalmologic examination, including assessment of best corrected visual acuity, refractive error, slit-lamp biomicroscopy, intraocular pressure (IOP) measurement with Goldmann applanation tonometry, gonioscopy, central corneal thickness (CCT) measured with ultrasound pachymetry (DGH Technology Inc., Exton, PA, USA), axial length measured by the IOL Master (Carl Zeiss Meditec, Dublin, CA, USA), dilated fundus examination, simultaneous stereophotography of the optic disc, standard automated perimetry (Humphrey Field Analyzer, 24-2 Swedish interactive threshold algorithm; Carl Zeiss Meditec), SD-OCT, OCT-A, and SS-OCT. Perimetry and all imaging tests were conducted within a 6-month period. 12 Systolic and diastolic blood pressure (BP) was measured at the height of the heart with an Omron Automatic BP instrument (Model BP791IT; Omron Healthcare, Inc., Lake Forest, IL, USA). Mean ocular perfusion pressure (MOPP) was calculated according to the following formula: MOPP ¼ Presence of an optic disc hemorrhage (DH) was defined as an isolated splinter or flame-shaped hemorrhage on the ONH based on standardized review of annually acquired optic disc stereophotographs. 12 To be included in the current study, POAG patients were required to have visible bPPA on fundus imaging with a temporal width ‡100 lm on at least one radial scan measured by the built-in caliper of the SD-OCT, BVCA ‡20/40, and open angles by gonioscopy. 12 Subjects with a history of ocular intervention (except for uncomplicated cataract or glaucoma surgery), intraocular diseases (e.g., diabetic retinopathy or nonglaucomatous optic neuropathy), or systemic diseases (e.g., stroke or pituitary tumor) that could influence the study results were excluded. Those with systemic hypertension (HT) and diabetes mellitus (DM) were included unless they were diagnosed to have diabetic or hypertensive retinopathy. Subjects with unreliable visual field (VF) or poor-quality imaging tests were also excluded. 12 POAG was defined as the presence of glaucomatous optic nerve damage (i.e., the presence of focal thinning, notching, localized or diffuse atrophy of retinal nerve fiber layer) and compatible repeated VF damage. Glaucomatous VF damage was defined as a VF outside normal limits on Glaucoma Hemifield Test or pattern standard deviation (PSD) outside 95% normal limits confirmed on two consecutive, reliable ( 20% fixation losses, 15% false positives and false negatives) tests. 12 
SD-OCT Imaging of b-Zone Parapapillary Area
Spectralis SD-OCT software (Glaucoma Module Premium Edition, version 1.7.0.0; Heidelberg Engineering GmbH) was used to visualize the ONH, including the PPA area, using a 939-mm-sized rectangle centered on the ONH (Fig. 1A1, B1 ). Details were described elsewhere. 19, 20 Briefly, 24 consecutive radial equidistant B-scans were acquired. Each B-scan, subtending 158, starting from the fovea-BM opening (BMO) axis was automatically determined by the device. From the 24 radial scans, six good-quality radial scans (quality score > 15) extending equidistant from the fovea-BMO axis were selected and included in the analysis (Fig. 1A1 ). 8 
Analysis of b-Zone Parapapillary Atrophy
The PPA region was evaluated using the Spectralis software feature that facilitated synchronous viewing of the colorconverted infrared fundus image and the selected location on the OCT scan. [6] [7] [8] The presence of the bPPA was defined as an area without the RPE. cPPA was defined as an area with the exposed Elschnig's ring between the optic disc boundary and the BM tips. Both bPPA and cPPA were required to have a temporal width ‡100 lm on at least one radial OCT scan image as measured by the built-in caliper of the Spectralis OCT (Fig.  1A1, B1) . 8, 9 The presence of bPPA and cPPA was determined independently by two experienced observers (MHS and PICM) who were masked to patients' clinical information. 8, 9 Disagreements were resolved by consensus between the two observers. If consensus could not be reached, the subject was excluded from the analysis.
Eyes with bPPA were divided into two groups according to the presence of cPPA (eyes with and without cPPA). The two groups were matched for the VF mean deviation (MD) to minimize the influence of glaucoma severity on the deep-layer microvasculature dropout. 12, 21 Specifically, patients with cPPA were matched to patients without cPPA into three groups based on the severity of their VF damage, (18 early POAG [MD > À6 dB], 12 moderate POAG [À12 dB MD À6 dB], and seven advanced POAG [MD < À12 dB]) by using a frequencymatching method. For specific analyses, eyes with cPPA were further classified into two subgroups: (1) those with discontinuous BM (PPA with some BM present) and (2) those lacking BM (PPA in which BM was absent throughout the entire area). 6, [8] [9] [10] In addition, focal cPPA was defined as cPPA localized to the superior or inferior hemiretina and not involving the fovea-BMO axis (Fig. 1A1) .
The bPPA and cPPA width were measured by the two observers (MHS and PICM) as the distance between the temporal optic disc boundary and the temporal margin of the RPE and BM tips, respectively, using the built-in caliper tool of the Spectralis SD-OCT. The average of bPPA and cPPA width measured by the two observers at six radial scans, for which the center was located at the fovea-BMO axis, was calculated (Fig. 1A1, B1) . 8 If the temporal margin of the ONH or bPPA was not well visualized, adjacent radial scans 158 apart were used for the measurement. bPPA þBM width was calculated as the difference between the bPPA and cPPA width.
OCT-A Imaging
The Angiovue incorporated in the Avanti SD-OCT system provides noninvasive visualization of the vasculature of various user-defined retinal layers by using the motion contrast technique and split-spectrum amplitude-decorrelation angiography method. Details have been described in elsewhere. 12, 13, [15] [16] [17] [22] [23] [24] Based on the quality review according to a standard protocol established by the Imaging Data Evaluation and Analysis (IDEA) Reading Center, OCT-A images with poor image quality, as defined by the following criteria, were excluded: (1) a signal strength index <48 (1 ¼ minimum, 100 ¼ maximum), (2) poor clarity, (3) residual motion artifacts visible as irregular vessel pattern or disc boundary on the enface angiogram, (4) local weak signal, (5) segmentation errors of the retinal nerve fiber layer (RNFL) and choroidal layer. The delineation of disc margin was reviewed for accuracy and adjusted manually as necessary according to standard protocols. 12 Vessel density (%) of the microvasculature located in the RNFL was calculated as the proportion of measured area occupied by flowing blood vessels on the ONH 4.5 3 4.5-mm field of view images centered on the optic disc. 12, 15, 16 Circumpapillary vessel density (cpVD) was calculated in a region defined as a 750-lm-wide elliptical annulus extending from the optic disc boundary based on 3608 global area. 12, 15, 16 Dropout of the Deep-Layer Microvasculature in the Parapapillary Atrophy Details for determining the presence of deep-layer microvasculature dropout within the bPPA is described elsewhere. 12 Briefly, two independent observers (MHS and PICM) masked to the patients' baseline characteristics and optic disc features qualitatively analyzed the bPPA area on 4.5 3 4.5-mm-sized choroidal layer vessel density map and the infrared fundus images acquired at the same positions. Discrepancies between the two observers were resolved by consensus, or if consensus could not be reached, the subject was excluded from the analysis. 12 A parapapillary deep-layer microvasculature dropout was defined as a complete loss of the choriocapillaris or the microvasculature within the scleral flange on both horizontal and enface choroidal layer vessel density maps (Fig. 1A2) . 12 To avoid false positives, dropout was required to be present in at least four consecutive horizontal scans and also to be ‡200 lm in diameter on at least one scan. 12 To avoid false negatives, reflectance or shadowing of the large vessels on the horizontal and en face images were excluded from the qualitative review. 12 For determining the presence of deeplayer microvasculature dropout within the cPPA in eyes with both dropout and cPPA, Spectralis SD-OCT and OCT-A images were aligned by registering images to large vessels (Fig. 1A1,  A2 ).
SS-OCT Imaging
The optic disc was imaged with the Topcon DRI SS-OCT device to determine the presence of focal lamina cribrosa (LC) defects and to measure choroidal thickness. Details have been described elsewhere. 12, [25] [26] [27] Both en face and horizontal SS-OCT images covering a 12 3 9-mm cube centered on the posterior pole were obtained using a three-dimensional raster scan (wide-field protocol) consisting of 256 serial horizontal Bscans. 12, [25] [26] [27] Poor-quality images with motion artifacts, quality score <50, clipped or poorly focused scans, poorly visible LC, or the segmentation failure of the choroidal layer were excluded. 12, [25] [26] [27] Poor visibility of the LC was defined as <70% visibility of the anterior laminar surface within the BM opening 12, 16 and segmentation failure of choroid as >25% discordance between the visual inspection and the automated identification of the BM and the chorioscleral interface. 12, 25, 26 Based on the horizontal and enface SS-OCT images, presence of focal LC defects was determined as laminar holes or laminar disinsertions violating the normal U-or W-shaped contour of the anterior laminar surface by the two observers (MHS and PICM) masked to the patients' clinical information. 12, 16, [28] [29] [30] [31] [32] [33] [34] The subject was excluded from the analysis if consensus between the two observers could not be reached. To be classified as a LC defect, the size of the focal LC defect was required to be ‡100 lm in diameter and >30 lm in depth in at least two consecutive scans.
12,16,28-32 These criteria were used to reduce the possibility that the LC defects were identified due to the hyporeflective vascular shadowing on the en face SS-OCT images and the disc photographs. 12, 16, 34 Total choroidal thickness was derived from the average choroidal thickness values from each of 108 locations from a 1-mm 2 -sized grid on the 12 3 9-mm wide-field SS-OCT images using standard SS-OCT software.
12,26

Data Analysis
Clinical characteristics, ONH morphologic parameters, and OCT-A-derived parameters were compared between eyes with and without cPPA. For continuous variables, Student's ttest and Mann-Whitney U test were used, depending on the normality test results. For categorical variables, the v 2 test was performed. 12 Univariable and multivariable logistic regression analyses were performed to determine the association between the parapapillary deep-layer microvasculature dropout and the bPPA microstructure. Variables with a P value of <0.10 in the univariable analyses were included in the multivariable logistic regression to adjust potential confounding factors in evaluating association between the deep-layer microvasculature dropout and bPPA microstructure. Interobserver agreement in determining the presence of the bPPA and cPPA, microvasculature dropout, and focal LC defects were assessed using the j coefficient. 35, 36 Interobserver agreement in measuring the bPPA and cPPA width was assessed using Bland-Altman analysis. Statistical software (MedCalc; Med-Calc, Inc., Mariakerke, Belgium) was used for statistical analyses, and the a level (type I error) was set at 0.05.
RESULTS
Study Population
One hundred forty eyes of 140 consecutive POAG DIGS patients who were evaluated for eligibility were included in this report. Of these 140 eyes, 27 were excluded for the following reasons: (1) poor-quality SD-OCT images (n ¼ 9), (2) an absence of bPPA (n ¼ 11), and (3) temporal bPPA width <100 mm (n ¼ 7). Among the remaining 113 eyes of 113 patients, 11 eyes were excluded due to poor OCT-A, nine eyes due to poor SS-OCT images, and one eye due to failure to reach the consensus between observers for the determination of the deep-layer microvasculature dropout. A final sample of 92 eyes was available for analysis; from this sample, 37 eyes with cPPA were matched for severity of VF damage by the frequencymatching method with 37 eyes without cPPA. Six of 37 eyes (16.2%) had cPPA lacking BM, whereas the remaining 31 eyes (83.8%) had discontinuous BM.
Clinical characteristics and presence of the deep-layer microvasculature dropout of the POAG patients (37 with and 37 without cPPA) were compared (Table 1) . Eyes with and without cPPA were not significantly different with respect to sex; CCT; ethnicity; presence of diabetes and systemic hypertension; antihypertensive and diabetes medication; number of glaucoma medications; IOP; systolic and diastolic BP MOPP; presence of the DH, VF MD, VF PSD; presence of the focal LC defect; and total choroidal thickness (all P > 0.10). Eyes with cPPA were more myopic and had longer axial lengths than those without cPPA (À2.4 6 2.5 vs. À0.5 6 1.6 diopter [D] for spherical equivalent and 25.2 6 1.4 vs. 24.0 6 1.0 mm for axial length; P < 0.05). Subjects who had eyes with cPPA were younger than those without cPPA with marginal significance (70.0 6 10.9 vs. 74.8 6 11.9 years; P ¼ 0.073). Upper nasal and inferonasal cpVD were significantly higher (54.1% 6 6.1% versus 50.2% 6 9.3% for upper nasal cpVD and 55.4% 6 10.1% versus 50.2% 6 9.3% for inferonasal cpVD; P < 0.05) in eyes with cPPA compared to eyes without cPPA. For all other RNFL and cpVD variables, the two groups were not different (all P > 0.10).
Interobserver Agreement for the Measurement
Interobserver agreement for determining the cPPA, cPPA with discontinuous BM, focal cPPA, deep-layer microvasculature dropout, and focal LC defect were excellent (j ¼ 0.86, 95% confidence interval [CI] 0.75-0.98, P < 0.001 for cPPA; j ¼ 0.89, 95% CI 0.69-1.00, P < 0.001 for cPPA with discontinuous BM; j ¼ 0.87, 95% CI 0.63-1.00, P < 0.001 for focal cPPA; j ¼ 0.86, 95% CI 0.74-0.98, P < 0.001 for dropout; and j ¼ 0.82, 95% CI 0.70-0.94, P < 0.001 for focal LC defect). 36 Based on the Bland-Altman plot, there was good agreement between the two observers in the bPPA and cPPA width as follows: the mean differences between the two observers were 21.5 lm (95% CI (Fig. 2) .
Deep-Layer Microvasculature Dropout and ONH Morphologic Parameters in Eyes With and Without cPPA
The ONH morphologic parameters measured by Spectralis SD-OCT and presence of the parapapillary deep-layer microvasculature dropout were compared between eyes with and without cPPA ( Table 2 ). Eyes with cPPA had a significantly higher prevalence of the deep-layer microvasculature dropout (75.7% versus 40.8%; P ¼ 0.004), larger bPPA width (411.4 6 211.5 vs. 277.4 6 97.8 lm; P < 0.001), and smaller bPPA þBM width (180.3 6 120.1 vs. 277.4 6 97.8 lm; P < 0.001). The two groups were not significantly different with respect to the BMO area (P ¼ 0.947) and fovea-BMO angle (P ¼ 0.900). Among 28 eyes with both cPPA and deep-layer microvasculature dropout, 26 eyes (92.9%) had cPPA areas containing dropouts (Fig. 1A1) .
bPPA Microstructure and Deep-Layer Microvasculature Dropout
Univariable and multivariable logistic regression analyses were used to evaluate the association between the width of bPPA, cPPA, and bPPA þBM and presence of the cPPA and parapapillary deep-layer microvasculature dropout (Tables  3-6 ).
In the univariable analysis (Table 3) , parapapillary deeplayer microvasculature dropout was significantly associated with the longer bPPA width (odds ratio [OR], 1.01; P ¼ 0.0008), cPPA presence (OR, 4.08; P ¼ 0.004), longer cPPA width (OR, 1.01; P ¼ 0.0052), lower cpVD (OR, 1.16; P < 0.001), worse VF MD (OR, 1.24; P < 0.001), presence of the focal LC defect (OR, 3.18; P ¼ 0.017), thinner total choroidal thickness (OR, 1.01; P ¼ 0.025), and longer axial length (OR, 1.49; P ¼ 0.036). Age; sex; race; CCT; IOP; systolic and diastolic BP; MOPP; prevalence of the DM, HT, and DH; BMO opening area; fovea-BMO angle; and bPPA þBM width were not significantly associated with microvasculature dropout (all P > 0.10).
Deep-Layer
In order to avoid issues of multicollinearity in the multivariable analysis, we evaluated the correlations between covariates. We found that VF MD, cpVD, and presence of the focal LC defects were significantly associated with one another. For this reason, the correlated variables were included in the multivariable model separately to avoid issues of multicollinearity.
cPPA Presence and Deep-Layer Microvasculature Dropout
Multivariable logistic regression analysis demonstrated that cPPA presence remained as a significant factor associated with the presence of dropout after adjusting for axial length, total choroidal thickness, and VF MD (OR, 5.34; P ¼ 0.012) (Table 4). Similarly, cPPA presence remained as a significant factor associated with deep-layer microvasculature dropout in models when focal LC defects (OR, 3.75; P ¼ 0.030) and cpVD (OR, 5.67; P ¼ 0.009) each were included in the multivariable models instead of VF MD (Table 4) .
cPPA Width and Deep-Layer Microvasculature Dropout
Longer cPPA width also remained as a significant factor associated with deep-layer microvasculature dropout after adjusting axial length, total choroidal thickness, and VF MD (OR, 1.01; P ¼ 0.039) ( Table 5 ). Similar patterns were observed in the multivariable analysis when cpVD was included instead of VF MD (OR, 1.01; P ¼ 0.048). When focal LC defect was included instead of VF MD, cPPA width was marginally significant (OR, 1.01; P ¼ 0.073) ( Table 5) .
Focal cPPA and Deep-Layer Microvasculature Dropout
Five of 37 eyes (13.5%) with cPPA had focal cPPA not involving the fovea-BMO axis, and all of them had deep-layer microvasculature dropout located within the cPPA region (Fig. 1A1) .
Eyes with focal cPPA had significantly shorter axial length than the remaining 32 eyes with cPPA involving the fovea-BMO axis (23.7 6 0.80 vs. 25.5 6 1.3 mm, P ¼ 0.005; independent ttest).
bPPA Width and Deep-Layer Microvasculature Dropout bPPA width was not significantly associated with the deep-layer microvasculature dropout after adjusting for axial length, total choroidal thickness, and VF MD (P ¼ 0.176) ( Table 6 ). Similar patterns were observed in the multivariable analysis when focal LC defect (P ¼ 0.112) and cpVD (P ¼ 0.166) were included instead of VF MD (Table 6 ). In all multivariable logistic regression analyses, worse VF MD was significantly associated with the deep-layer microvasculature dropout (all P < 0.05), while axial length and total choroidal thickness were not significantly associated with the dropout (all P > 0.10) (Tables 4-6).
DISCUSSION
This study found that glaucomatous eyes with cPPA had a significantly higher prevalence of parapapillary deep-layer microvasculature dropout than those with bPPA þBM (75.7% versus 40.8%, P ¼ 0.004; v 2 test). Furthermore, parapapillary deep-layer microvasculature dropout was positively associated with the presence and longer width of the cPPA even after adjusting for other potentially confounding factors such as axial length, choroidal thickness, glaucoma severity, and presence of focal LC defects. 12 However, width of the bPPA þBM was not associated with deep-layer microvasculature dropout. These findings suggest that parapapillary deep-layer microvasculature dropout may be associated with a continuum of cPPA with exposed scleral flange ranging from completely present to completely absent but not with the area of bPPA þBM with atrophic change of the RPE.
Our previous study 12 showed that deep-layer microvasculature dropout within the bPPA was associated with more advanced disease status, presence of a focal LC defect, reduced superficial microvasculature, thinner choroidal thickness, and lower diastolic BP. However, in the previous study, the association between the dropout and microstructure of bPPA was not evaluated. 12 The current study demonstrated that cPPA area was significantly associated with the presence of deep-layer microvasculature dropout. These results are consis- tent with previous studies suggesting that penetrating branches of the short posterior ciliary artery passing through the scleral flange may be subject to increased mechanical stress and strain. 37, 38 Therefore, cPPA with exposed scleral flange may be a sign of increased IOP-related scleral tension that leads to disruption of the deep-layer microvasculature. Further measurement of the IOP-related stress or strain and subsequent vascular changes according to the presence and continuum of the exposed scleral flange are warranted to elucidate this speculation.
However, how the relationship between the cPPA and parapapillary deep-layer microvasculature dropout relates to the pathophysiology of glaucoma is still unclear. The current results do not concur with other studies suggesting that the presence and width of the cPPA may be associated with slower progression of glaucoma 9, 10 and with studies suggesting that deep-layer microvasculature dropout is associated with a more advanced disease status. 11, 12 Also, the presence and width of the cPPA is known to be associated with axial elongation of the eye globe. 6, 7 Therefore, as axial globe elongation is halted with aging, the mechanical stress due to scleral stretching may also be relieved. Possible explanations for the discrepancies among studies may be attributed to differences of the study population and definition regarding the microstructure of the PPA. 6, 7 In the current study, glaucomatous eyes with cPPA had significantly longer axial lengths, larger bPPA width, and smaller BMO area than those without cPPA. In a univariable regression for determining factors associated with the deeplayer microvasculature dropout, axial length and bPPA width remained as associated factors as well as the presence and width of cPPA. However, in multivariable regression, only the width and presence of the cPPA were significantly associated with deep-layer microvasculature dropout; axial length and bPPA width, therefore, were excluded in most models. One possible explanation for these results is a relatively small number of eyes with high myopia (axial length ‡ 26.5 mm or spherical equivalent ‡ À6.0 D) (n ¼ 7) and older patients with cPPA (72.4 years) than those of previous studies (age ranging between 42.9 and 58.9 years). 6,9,10 Therefore, there were proportionately fewer cPPA eyes that completely lacked BM (16.2%, n ¼ 6) than in previous studies (percentage of cPPA completely lacking BM ranging between 18.8% and 35.6%).
6,9,10 Second, a pathogenic process other than axial elongation may contribute to the development of a certain type of bPPA devoid of BM and vascular disruption. In this study, five (13.5%) of 37 eyes with cPPA had focal cPPA that does not involve the fovea-BMO axis, and their axial length was shorter than that of the remaining 32 eyes with cPPA involving the fovea-BMO axis (23.7 vs. 25.5 mm, P ¼ 0.005; independent ttest). In addition, eyes with focal cPPA in our study have relatively shorter axial lengths (mean ¼ 23.7 mm) than those with cPPA in previous studies (mean axial length ranging between 25.74 and 26.42 mm). 6, 9, 10 It is interesting that all eyes with focal cPPA had deep-layer microvasculature dropout. Given that axial growth of the globe leads to the temporal dragging of the ONH, 39 it is less likely that cPPA induced by axial elongation does not involve the fovea-BMO axis, a central horizontal axis of the ONH. Therefore, focal cPPA not involving the fovea-BMO axis may reflect a local alteration of the BM and loss of an adjacent deep-layer microvasculature derived by mechanisms other than those from axial elongation. However, the role of focal cPPA and its relationship with the deep-layer microvasculature disruption in the pathophysiology of glaucoma can only be confirmed by future studies with a larger number of study subjects with focal cPPA. Further longitudinal studies with larger numbers of normal and glaucomatous eyes with high myopia are required to determine whether the rate of glaucoma progression differs according to the axial length, type of cPPA, and the presence of deep-layer microvasculature dropout.
The current finding that bPPA width was associated with the deep-layer microvasculature dropout in univariable regression analysis, but not in multivariable regression analysis, concurs with our previous results. 12 Furthermore, bPPA þBM width was not associated with dropout in univariable regression analysis. However, these results do not correspond with previous histologic studies showing that age-related atrophy of the RPE-BM complex, known to be a main mechanism of the bPPA þBM , was associated with the complete loss of adjacent choriocapillaris. 3, 40 Differences across the studies may be related to differences in study design. The present study utilized an in vivo imaging device, whereas previous studies used histopathologic analysis. Technical limits of the current OCT-A device and qualitative analysis of the deep-layer microvasculature dropout may also hinder detection of the subtle loss of parapapillary deep-layer microvasculature in this study. 12 Further improvement of the OCT-A technique and quantitative analysis of the deep-layer microvasculature is needed.
Despite controversy over the relationship between the choroidal thickness and deep-layer microvasculature dropout, 12, 17 the current result concurs with a recently published study that choroidal thickness is not related to the presence of the deep-layer microvasculature dropout. 17 Considering their topographical relationship, it will be important to investigate the association between the parapapillary deep-layer microvasculature and the adjacent choroidal structure outside the PPA.
The present study has several limitations. First, eyes with and without cPPA were matched by the severity of glaucoma to minimize the possibility of selection bias that more severe glaucoma eyes are more likely to have deep-layer microvasculature dropout. Therefore, caution is needed in interpreting the study results that cPPA was associated with microvasculature dropout. However, matching did have an advantage as it made for a more controlled experiment since both deep-layer microvasculature dropout and presence of the cPPA were known to be associated with the glaucomatous severity. [9] [10] [11] [12] Future studies with larger numbers of glaucomatous eyes with typical cPPA completely devoid of BM are warranted. Second, as three devices were used for determining the presence of cPPA in this study, variability of registration across images may have reduced the strength of the associations. Spectralis SD-OCT and SS-OCT, instruments that enabled good visualization of the deeper layers, were utilized to visualize the RPE and BMO tips, choroidal tissue, and presence of focal LC defects, whereas Avanti OCT-A was utilized to assess deep-layer microvasculature. 12 However, the three devices were aligned by using large retinal vessels for determining the location of dropout within the cPPA, thereby reducing the likelihood of large misalignment between images. 16 Third, it is still unclear whether optic disc margin based on the infrared fundus image may reflect an anatomically correct structure, since disc margin does not uniformly correspond to the BMO-based disc margin of SD-OCT images. 6, 9, 19, 20, 41 This may limit an accurate determination of the RPE and BM and thus may lead to a variation in the measurement of the bPPA, cPPA, and bPPA þBM width. However, interobserver agreement for measurement of the bPPA and cPPA width was good (Fig. 2) , and adjunct usage of the infrared fundus images synchronous to the SD-OCT also helped to accurately determine the RPE and BMO tips.
In conclusion, parapapillary deep-layer microvasculature dropout was significantly associated with the presence and larger width of the bPPA without BM (cPPA) in glaucomatous eyes, but not with the width of bPPA with intact BM. These findings suggest that the increased strain and stress on the exposed scleral flange without BM rather than atrophic change of the RPE may be associated with the complete loss of parapapillary deep-layer microvasculature. How this relationship between the mechanical and vascular parameters of the ONH affects the pathophysiology of the development and progression of glaucoma remains to be elucidated.
